These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 20046070)

  • 21. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.
    Gryczke A; Schminke S; Maniruzzaman M; Beck J; Douroumis D
    Colloids Surf B Biointerfaces; 2011 Sep; 86(2):275-84. PubMed ID: 21592751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of Solifenacin Succinate Functional Particles Embedded in a Gelling-Swelling Layer (PEGS) and Their Formulation in Orally Disintegrating Tablets.
    Ijitsu S; Hoashi Y; Hori K; Okimoto K; Kai T; Yoshida M; Uchida T
    Chem Pharm Bull (Tokyo); 2021 May; 69(5):456-463. PubMed ID: 33627574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating method.
    Sugiura T; Uchida S; Namiki N
    Chem Pharm Bull (Tokyo); 2012; 60(3):315-9. PubMed ID: 22382410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
    Gulsun T; Ozturk N; Kaynak MS; Vural I; Sahin S
    Pharmazie; 2017 Jul; 72(7):389-394. PubMed ID: 29441935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and evaluation of bitter taste-masked orally disintegrating tablets of high memantine hydrochloride loaded granules coated with polymer via layering technique.
    Kadota K; Terada H; Fujimoto A; Nogami S; Uchiyama H; Tozuka Y
    Int J Pharm; 2021 Jul; 604():120725. PubMed ID: 34029663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.
    Nakamura S; Fukai T; Sakamoto T
    AAPS PharmSciTech; 2021 Dec; 23(1):37. PubMed ID: 34950985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the development of rapidly disintegrating hyoscine butylbromide tablets.
    Khattab IS; Zaghloul1 AA; Afouna MI
    Drug Discov Ther; 2007 Aug; 1(1):61-4. PubMed ID: 22504365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
    Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.
    Yan YD; Woo JS; Kang JH; Yong CS; Choi HG
    Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical Palatability.
    Takano H; Uchida S; Kashiwagura Y; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Chem Pharm Bull (Tokyo); 2019; 67(2):112-119. PubMed ID: 30713270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
    Douroumis DD; Gryczke A; Schminke S
    AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method.
    Ishikawa T; Mukai B; Shiraishi S; Utoguchi N; Fujii M; Matsumoto M; Watanabe Y
    Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):134-9. PubMed ID: 11217097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
    Ge Z; Yang M; Wang Y; Shan L; Gao C
    Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
    Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, evaluation, and pharmacokinetics in beagle dogs of a taste-masked flunixin meglumine orally disintegrating tablet prepared using hot-melt extrusion technology and D-optimal mixture design.
    Xu Y; Yan G; Wen X; Wu L; Deng R; Liang Q; Zhang L; Chen H; Feng X; He J
    Eur J Pharm Sci; 2022 Jan; 168():106019. PubMed ID: 34563655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique.
    Shah PP; Mashru RC
    AAPS PharmSciTech; 2008; 9(2):494-500. PubMed ID: 18431657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.
    Morott JT; Pimparade M; Park JB; Worley CP; Majumdar S; Lian Z; Pinto E; Bi Y; Durig T; Repka MA
    J Pharm Sci; 2015 Jan; 104(1):124-34. PubMed ID: 25410968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.